fda authorizes monoclonal antibodies for generation of covid-19
fda authorizes monoclonal antibodies for generation of covid-19
the emergency authorization of these monoclonal antibodies administered together offers health care providers another tool in combating the pandemic, said patrizia cavazzoni, m.d., acting director of the fdas center for drug evaluation and research.